socalTECH

JULY 28, 2020

San Diego-based telemedicine and telehealth software developer AristaMD has added another $6M to the company's Series B, bringing the total to $24M, the company said on Monday. The funding came from Ascension Ventures and.406 The funding came from Ascension Ventures and.406 READ MORE>>.

Funding 100

Funding Avalon San Diego Software Development 100

socalTECH

DECEMBER 2, 2010

San Diego-based venture capital firm Avalon Ventures has led an investment in a cloud computing company, Standing Cloud , based in Boulder, Colorado. According to Standing Cloud, it received a $3M, Series B financing from Avalon, which also included the firm's prior investor, The Foundry Group.

Avalon 154

Avalon Invest Cloud Computing San Diego 154

socalTECH

MARCH 29, 2021

San Diego-based Fortis Therapeutics, a biotechnology startup developing treatments for late-stage prostate cancer and multiple myeloma, has raised $40M in a Series A financing, the company said on Monday.

Avalon 113

Avalon San Diego Research Funding 113

socalTECH

MARCH 5, 2013

San Diego-based Carolus Therapeutics , a developer of biopharmaceuticals aimed at treating acute and chronic inflammation, has scored $2.25M in a debt funding round, according to financing provider Square 1 Bank. According to Square 1, the new funding will go support future growth at Carolus. READ MORE>>.

Avalon 147

Avalon Funding San Diego Develop 147

socalTECH

APRIL 30, 2014

San Diego-based biopharmaceuticals developer Otonomy --which is developing treatments for inner and middle ear disorders--has roped in a big, $49M funding, the company announced this morning. READ MORE>>. otonomy biopharmaceuticals biotech lifescience venture capitall inner disorder disease'

Funding 138

Funding Avalon San Diego Capital 138

Xconomy

SEPTEMBER 27, 2016

[ Note: The headline has been corrected to better describe the company’s type of funding. Fortis Therapeutics, a new San Diego biotech, has raised $18 million in initial funding to develop drugs for hard-to-treat prostate and bone marrow cancers. 9/27/16, 2:09 p.m. Bregua Corp.,

Avalon 40

Avalon Funding Startup San Diego 40

socalTECH

SEPTEMBER 27, 2016

San Diego-based Fortis Therapeutics , a new biotech company in the immuno-oncology area, announced this morning that it has raised $18M in a Series A funding. The funding was led by Avalon Ventures and also included Bregua Corporation, Lilly Asia Ventures, Osage University Partners, and Vivo Capital.

Avalon 100

Avalon San Diego Research Capital 100

socalTECH

NOVEMBER 22, 2013

San Diego-based Avalon Ventures announced this morning that it has launched a new company, Sitari Pharmaceuticals , with $10M in a Series A financing.

Avalon 153

Avalon San Diego Capital Funding 153

socalTECH

OCTOBER 22, 2014

San Diego-based StackIQ , which develops IT automation tools for the enterprise, has raised $6M in a Series B funding round, according to the company. The new funding came from Grayhawk Capital, Keshif Ventures, DLA Piper, and OurCrowd, as well as Anthem Venture Partners and Avalon Ventures. READ MORE>>.

Avalon 174

Avalon Anthem San Diego Venture Capital 174

socalTECH

SEPTEMBER 10, 2014

San Diego-based Avelas Biosciences , which is developing cell penetrating peptides to light up cancerous tissue in patients during surgery, has raised $7.4M in a Series B funding. The second tranche of the company''s Series B came from investors Avalon Ventures, Torrey Pines Investment and WuXi PharmaTech Investments.

Avalon 147

Avalon San Diego Venture Capital Research 147

Xconomy

SEPTEMBER 11, 2019

GlaxoSmithKline is acquiring a startup it helped launch in 2013 as part of an alliance with life sciences venture capital firm Avalon Ventures. Avalon said Tuesday that GSK (NYSE: GSK ) has agreed to buy the company, Sitari Pharmaceuticals, which has been developing a treatment for celiac disease.

Avalon 56

Avalon Invest Southern California Develop 56

socalTECH

AUGUST 18, 2016

San Diego-based biopharmaceuticals developer Avelas Biosciences has raised $20M in a Series C funding, according to the company. The new funding was led by Pharmstandard International, S.A., Avelas Biosciences is developing treatments for cancer. Avelas Biosciences is developing treatments for cancer.

Avalon 100

Avalon San Diego Invest Funding 100

socalTECH

JANUARY 9, 2014

San Diego-based Avelas Biosciences announced today that it has raised $6.85M in a Series B funding round, for the company''s technology for illuminating cancer cells. The company said the funding came from Avalon Ventures, and also included Torrey Pines Investment, WuXi AppTec, and an additional, un-named investor.

Avalon 138

Avalon San Diego Funding Capital 138

socalTECH

JULY 20, 2016

San Diego-based Synthorx , a developer of protein therapeutics technology, said it has raised $10M in a Series B financing this morning. The funding was led by RA Capital Management, and also included Avalon Ventures and Correlation Ventures.

Avalon 100

Avalon San Diego Research Capital 100

socalTECH

NOVEMBER 28, 2016

San Diego-based biotechnology developer Synthorx announced today that it has named Patrick J. Synthorx is focused on developing novel protein therapeutics, and is venture backed by RA Capital Management, Avalon Ventures and Correlation Ventures. The company announced a funding round in July. READ MORE>>.

Avalon 100

Avalon San Diego Capital Funding 100

socalTECH

JULY 17, 2014

invested in San Diego, and $66.53M invested in Orange County during the period. The biggest investments for the quarter were for Culver City-based NantHealth , the digital health venture of billionaire Dr. Patrick Soon-Shiong, which raised $135M in a funding; El Segundo-based Prodege (aka Swagbucks), which raised $60.1M

Southern California 240

Southern California El Segundo Culver City Orange County 240

socalTECH

DECEMBER 6, 2012

San Diego-based Avelas Biosciences has raised $7.65M in a Series A funding round, which it says will go towards clinical studies for its technology for real-time tumor visualization. The funding came from Avalon Ventures. The firm's CEO is currently Jay Lichter, who is also a Managing Director at Avalon Ventures.

Avalon 138

Avalon San Diego Study Technology 138

socalTECH

JANUARY 26, 2017

San Diego-based AnaptysBio , which develops antibodies for treating inflammation, has raised $75.0M AnaptysBio is backed by Frazier Healthcare, Novo A/S, Avalon Ventures, Alloy Ventures, Biotechnology Value Fund, HBM Healthcare Investments, and others. Anaptys priced its IPO on Wednesday night at $15.00

Avalon 100

Avalon San Diego Pricing Invest 100

socalTECH

JUNE 3, 2011

San Diego-based Otonomy , a firm developing products to treat disorders of the inner and middle ear, looks to have pulled in $14.2M In the filing, the firm said the new funding came on May 18th. more in a tranched financing which was originally announced last August, according to a regulatory filing by the firm this week.

Funding 140

Funding Avalon San Diego Product 140

socalTECH

JULY 22, 2016

San Diego-based AristaMD , which is developing software tools to help coordinate referrals by physicians to specialists, has raised $11M in a Series A funding round. The funding was led by Avalon Ventures, and also included Correlation Ventures.

Avalon 100

Avalon San Diego Tool Research 100

socalTECH

JANUARY 17, 2017

San Diego-based AnaptysBio , which develops antibodies for treating inflammation, has set its estimated IPO pricing range, saying on Tuesday that it expects to price its IPO at between $14.00 and $16.00 The company is selling 4,000,000 shares of its common stock on the NASDAQ Global Select Market as ANAB. as early as Thursday.

Pricing 100

Pricing Avalon Southern California Venice 100

socalTECH

SEPTEMBER 4, 2013

San Diego-based biopharmaceuticals firm Otonomy announced this morning that it has raised $45.9M in a Series C, equity funding. Otonomy is a biopharmaceuticals firm developing treatments for diseases and disorders of the inner and middle ear. Khuong of OrbiMed wil join the company''s board with the funding.

Avalon 138

Avalon San Diego Equity Funding 138

socalTECH

MARCH 13, 2014

San Diego-based AnaptysBio , a biopharmaceuticals firm focused on the development of therapeutic antibodies, announced a deal today with TESARO. AnapytsBio is venture backed by Alloy Ventures, Avalon Ventures, Frazier Healthcare Ventures and Novo A/S. READ MORE>>.

Avalon 138

Avalon San Diego Venture Capital Research 138

socalTECH

NOVEMBER 3, 2014

San Diego-based Proximal Data , a developer of storage caching software aimed at use with virtualized systems, has been acquired by Samsung Electronics , Samsung said today. Proximal Data was venture backed by Divergent Ventures and Avalon Ventures, and had only announced around $5M in funding.

Avalon 138

Avalon San Diego Software Acquisition 138

socalTECH

DECEMBER 4, 2015

San Diego-based Enlibrium announced Thursday that it has raised $15M in a Series A financing, to go towards cancer therapeutics. The funding was led by Avalon Ventures and TPG Biotech, and also included Correlation Ventures and Osage University Partners.

UCLA 100

UCLA Avalon San Diego Los Angeles 100

socalTECH

APRIL 20, 2012

San Diego-based Chumby , which had developed Internet-connected, alarm-clock like devices and similar technology, has shut down, according to a report Friday. The firm had raised on the order of $25M in funding for its efforts. READ MORE>>.

Report 157

Report Avalon San Diego News 157

socalTECH

JUNE 9, 2010

San Diego-based Otonomy , a biopharmaceuticals firm developing drug therapies to treat inner and middle ear disorders, has raised $10.56M as part of an ongoing, $26.0M fundraising effort, according to a regulatory filing by the firm.

Avalon 159

Avalon San Diego Venture Capital Capital 159

socalTECH

JULY 21, 2011

San Diego-based Amira Pharmaceuticals , a developer of small molecule pharmaceuticals for treating inflammatory and fibrotic diseases, has agreed to be acquired by Bristol-Myers Squibb , the firms said late Thursday. The firm had raised somewhere around $40M in venture capital funding.

Avalon 150

Avalon San Diego Venture Capital Capital 150

socalTECH

APRIL 1, 2013

San Diego-based Proximal Data , which develops serve-side caching software for accelerating I/O access to virtualized machines, said this morning that it has raised $2M in a Series B round of funding. The funding came from Divergent Ventures, along with existing investors Avalon Ventures.

Software 124

Software Avalon San Diego Design 124

socalTECH

MAY 27, 2009

San Diego-based E-Band Communications , a developer of millimeter-wave wireless transmission systems, said Wednesday that the firm has raised a Series C financing round. Amount of the funding was not disclosed by the firm. E-Band said the funding will go towards accelerating its business operations expansion.

Avalon 100

Avalon Funding San Diego Capital 100

socalTECH

AUGUST 30, 2010

San Diego-based Otonomy , a biopharmaceuticals firm developing products to treat disorders of the inner and middle ear, announced today that it has raised $38.5M The round was led by Novo Ventures and RiverVest Venture Partners, and also includes Domain Associates, TPG Biotech, and Avalon Ventures.

Avalon 150

Avalon San Diego Venture Capital Study 150

socalTECH

JUNE 4, 2012

San Diego-based Awarepoint , which develops real-time, location systems used for tracking patents and assets in a healthcare environment, said today that it has raised $14M in an additional financing round. HHIF will add a representative to Awarepoint's board with the funding. HHIF contributed $7.5M

Avalon 140

Avalon San Diego Patents Invest 140

socalTECH

JUNE 9, 2009

San Diego-based aFraxis , a stealth-mode firm developing treatments for Fragile X Syndome and autism, has raised $750,000 in a funding round, according to a regulatory filing by the firm Tuesday. Details on the funding have not been announced, however, the company is venture backed by Avalon Ventures.

Avalon 100

Avalon San Diego Venture Capital Capital 100

socalTECH

JUNE 11, 2010

San Diego-based Otonomy , which is developing treatments for Meniere's disease, said today that it has raised $10M in a Series A financing round. The round came from Avalon Ventures. Otonomy is headed by Jay Lichter, who is also a managing director at Avalon Ventures. READ MORE>>.

Avalon 113

Avalon San Diego Study Capital 113

socalTECH

OCTOBER 4, 2010

San Diego-based Chumby , maker of the alarm-clock sized, Internet device, has raised another $3.0M in funding, according to a regulatory filing by the firm Monday. According to the filing, the funding came in the form of debt and warrants, most likely a convertible debt round. Source of the new funding was not disclosed.

Avalon 145

Avalon San Diego Venture Capital Software 145

socalTECH

JULY 18, 2013

invested across 17 deals; San Diego was third, with $147.75M in 18 deals. The biggest deal for the quarter was for Venice-based photo messaging app developer Snapchat , which raised a huge, $60M funding round in the quarter. Orange County was second, with $161.9M

Southern California 187

Southern California Venture Capital Tech Coast Angels Capital 187

socalTECH

JUNE 1, 2010

San Diego-based Chumby , the maker of the Internet-connected, Linux-based clock radio, has upped its Series B funding to $8.78M, according to a regulatory filing from the firm this week. According to the filing, the firm is in the midst of raising up to $9.786M in the round. READ MORE>>.

Avalon 150

Avalon San Diego Venture Capital News 150